Dr. Cheung graduated from the University College London. He obtained his PhD in The University of London (concentration in Immunology) in 2015. He received his postdoctoral training at the William Harvey Research Institute, London. He served as a Research Assistant Professor at the Chinese University of Hong Kong between 2018 and 2021, after which he joined Hong Kong Baptist University in 2021.

Dr. Cheung’s research interests are immunology and metabolic diseases. His research work has been published in internationally renowned journals including Immunity, Nature Communications, Clinical Cancer Research, PNAS and British Journal of Pharmacology. 

As an immunologist, I possess a deep passion for my field and extensive knowledge in cardiovascular, cancer, and immunology. Currently, my primary focus lies in T Cell therapy.

In our research program, we utilize a range of approaches including metabolomics, immunology, bioinformatics, and molecular biology to identify the causes of cancer in various tumor types and explore key metabolic pathways involved in carcinogenesis. Our laboratory operates a cutting-edge metabolomics program that quantitatively profiles endogenous small-molecule metabolites and trace elements from biological specimens such as blood, urine, saliva, cell lysates, and tissues from experimental animals and human subjects. This program involves unbiased metabolic profiling and data mining, metabolite annotation, and biological interpretation, as well as targeted analysis of metabolic flux and pathways using isotope-labeled metabolites and high sensitivity, high throughput LC-MS-MS and GC-MS platforms.